Guideline

WHO recommendations on drug treatment for non-severe hypertension in pregnancy

Year of Publication

2020

Issuing Institution

World Health Organization

Links

WHO IRIS,WHO IRIS

Recommendations

2 included recommendations

Women with non-severe hypertension during pregnancy should be offered antihypertensive drug treatment in the context of good quality antenatal care follow-up.

Status

Maintained

Context specific recommendation

Only in specific contexts

Certainty of evidence

Very low

Oral alpha-agonist (methyldopa) and beta-blockers should be considered as effective treatment options for non-severe hypertension during pregnancy.

Status

Maintained

Context specific recommendation

Only in specific contexts

Certainty of evidence

Very low